KR950703064A - 세포증식의 저해물질, 그의 제조방법 및 이용방법 - Google Patents
세포증식의 저해물질, 그의 제조방법 및 이용방법Info
- Publication number
- KR950703064A KR950703064A KR1019950700509A KR19950700509A KR950703064A KR 950703064 A KR950703064 A KR 950703064A KR 1019950700509 A KR1019950700509 A KR 1019950700509A KR 19950700509 A KR19950700509 A KR 19950700509A KR 950703064 A KR950703064 A KR 950703064A
- Authority
- KR
- South Korea
- Prior art keywords
- inhibitors
- manufacturing
- methods
- cell proliferation
- proliferation
- Prior art date
Links
- 230000004663 cell proliferation Effects 0.000 title 1
- 239000003112 inhibitor Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H19/00—Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/4756—Neuregulins, i.e. p185erbB2 ligands, glial growth factor, heregulin, ARIA, neu differentiation factor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
- C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
- C07K16/22—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against growth factors ; against growth regulators
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biochemistry (AREA)
- Medicinal Chemistry (AREA)
- Genetics & Genomics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Toxicology (AREA)
- Gastroenterology & Hepatology (AREA)
- Pharmacology & Pharmacy (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Immunology (AREA)
- Wood Science & Technology (AREA)
- Neurosurgery (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Neurology (AREA)
- Microbiology (AREA)
- Biomedical Technology (AREA)
- General Engineering & Computer Science (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (5)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US92733792A | 1992-08-10 | 1992-08-10 | |
US95174792A | 1992-09-25 | 1992-09-25 | |
US98408592A | 1992-12-01 | 1992-12-01 | |
US1139693A | 1993-01-29 | 1993-01-29 | |
PCT/US1993/007491 WO1994003644A1 (en) | 1992-08-10 | 1993-08-10 | Inhibitors of cell proliferation, their preparation and use |
Publications (1)
Publication Number | Publication Date |
---|---|
KR950703064A true KR950703064A (ko) | 1995-08-23 |
Family
ID=27486082
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1019950700509A KR950703064A (ko) | 1992-08-10 | 1995-02-10 | 세포증식의 저해물질, 그의 제조방법 및 이용방법 |
Country Status (7)
Country | Link |
---|---|
US (1) | US5876973A (ko) |
EP (1) | EP0656069A4 (ko) |
JP (1) | JPH08500246A (ko) |
KR (1) | KR950703064A (ko) |
AU (1) | AU693767B2 (ko) |
CA (1) | CA2142185A1 (ko) |
WO (1) | WO1994003644A1 (ko) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6515009B1 (en) | 1991-09-27 | 2003-02-04 | Neorx Corporation | Therapeutic inhibitor of vascular smooth muscle cells |
US6750196B1 (en) * | 1995-03-27 | 2004-06-15 | Acorda Therapeutics | Methods of treating disorders of the eye |
US5912326A (en) * | 1995-09-08 | 1999-06-15 | President And Fellows Of Harvard College | Cerebellum-derived growth factors |
WO1999053097A2 (en) * | 1998-04-15 | 1999-10-21 | The Government Of The United States Of America, As Represented By The Secretary Of The Department Of Health And Human Services Centers For Disease Control And Prevention | Method for developing degenerate pcr primers |
US8623822B2 (en) | 2002-03-01 | 2014-01-07 | Bracco Suisse Sa | KDR and VEGF/KDR binding peptides and their use in diagnosis and therapy |
US7211240B2 (en) * | 2002-03-01 | 2007-05-01 | Bracco International B.V. | Multivalent constructs for therapeutic and diagnostic applications |
US7794693B2 (en) * | 2002-03-01 | 2010-09-14 | Bracco International B.V. | Targeting vector-phospholipid conjugates |
WO2004065621A1 (en) | 2002-03-01 | 2004-08-05 | Dyax Corp. | Kdr and vegf/kdr binding peptides and their use in diagnosis and therapy |
US7261876B2 (en) | 2002-03-01 | 2007-08-28 | Bracco International Bv | Multivalent constructs for therapeutic and diagnostic applications |
EP1603935A4 (en) * | 2003-03-03 | 2007-03-21 | Dyax Corp | SPECIFIC TO HGF RECEPTOR (cMET) BINDING PEPTIDES AND THEIR USE |
CN101309930A (zh) * | 2003-08-19 | 2008-11-19 | 阿戈斯生物科技有限公司 | ErbB配体的剪接变体、其组合物及其用途 |
EP3777878A1 (en) | 2008-08-15 | 2021-02-17 | Acorda Therapeutics, Inc. | Compositions and methods for treatment during non-acute periods following cns neurological injury |
US9850300B2 (en) | 2013-03-15 | 2017-12-26 | The Regents Of The University Of Michigan | Compositions and methods relating to inhibiting cancer cell growth and/or proliferation |
Family Cites Families (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4935341A (en) * | 1986-06-04 | 1990-06-19 | Whitehead Institute For Biomedical Research | Detection of point mutations in neu genes |
AU7180787A (en) * | 1986-04-22 | 1987-10-29 | Salk Institute For Biological Studies, The | Fibroblast growth factor |
US4968603A (en) * | 1986-12-31 | 1990-11-06 | The Regents Of The University Of California | Determination of status in neoplastic disease |
WO1989000051A1 (en) * | 1987-07-07 | 1989-01-12 | Cytrx Biopool Ltd. | Fibrin-binding compound and method |
FR2636324A1 (fr) * | 1988-09-15 | 1990-03-16 | Sgn Soc Gen Tech Nouvelle | Installation pour le relevage rapide et l'empilage de plaques de verre |
GB8917091D0 (en) * | 1989-07-26 | 1989-09-13 | Martin Moffatt Ltd | Image reader and cursor |
US5026940A (en) * | 1989-09-08 | 1991-06-25 | Catalytica, Inc. | Manufacture of 4,4'-diisopropylbiphenyl |
EP0536299B1 (en) * | 1990-06-27 | 2001-06-06 | Biogen, Inc. | Surface complexed lymphotoxin |
AU650292B2 (en) * | 1990-09-14 | 1994-06-16 | United States of America, as represented by the Secretary, U.S. Department of Commerce, The | A non-mitogenic competitive HGF antagonist |
DE69229597D1 (de) * | 1991-01-14 | 1999-08-19 | Univ Georgetown | Wachstumsfaktor-ligand, der an den erbb-2-rezeptor bindet und die zellulären reaktionen induziert |
GB9107566D0 (en) * | 1991-04-10 | 1991-05-29 | Ludwig Inst Cancer Res | Glial mitogenic factors,their preparation and use |
US5530109A (en) * | 1991-04-10 | 1996-06-25 | Ludwig Institute For Cancer Research | DNA encoding glial mitogenic factors |
IL101943A0 (en) * | 1991-05-24 | 1992-12-30 | Genentech Inc | Structure,production and use of heregulin |
US5367060A (en) * | 1991-05-24 | 1994-11-22 | Genentech, Inc. | Structure, production and use of heregulin |
-
1993
- 1993-08-10 AU AU50026/93A patent/AU693767B2/en not_active Ceased
- 1993-08-10 EP EP94906740A patent/EP0656069A4/en not_active Withdrawn
- 1993-08-10 CA CA002142185A patent/CA2142185A1/en not_active Abandoned
- 1993-08-10 WO PCT/US1993/007491 patent/WO1994003644A1/en not_active Application Discontinuation
- 1993-08-10 JP JP6505616A patent/JPH08500246A/ja active Pending
-
1995
- 1995-02-10 KR KR1019950700509A patent/KR950703064A/ko not_active Application Discontinuation
- 1995-06-06 US US08/469,660 patent/US5876973A/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP0656069A4 (en) | 1996-07-10 |
AU5002693A (en) | 1994-03-03 |
EP0656069A1 (en) | 1995-06-07 |
US5876973A (en) | 1999-03-02 |
WO1994003644A1 (en) | 1994-02-17 |
JPH08500246A (ja) | 1996-01-16 |
CA2142185A1 (en) | 1994-02-17 |
AU693767B2 (en) | 1998-07-09 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TR26456A (tr) | IKIZ-BÖLMELI PAKETLER VE IKIZ-BÖLMELI PAKETLERIN üRETILMESINE MAHSUS YÖNTEMLER VE CIHAZLAR. | |
NO931443D0 (no) | Forsinket syreopploeselig broennsement og metoder | |
DK543189A (da) | Lysyloxidaseinhibitorer og deres anvendelse | |
DE69031434D1 (de) | Spontane Sprach- und Datenbenachrichtigung | |
NO962269D0 (no) | Enzyminhibitorer | |
DE69433168D1 (de) | In vitro vermehrung von stammzellen | |
KR960701252A (ko) | 스티치접합된 물품 및 그 제조 방법(stitchbonded articles and method of making same) | |
KR900009894A (ko) | 피복 조성물 및 그 제조방법 | |
NO942064D0 (no) | yminhibitorer | |
DK317287D0 (da) | Reduktase-inhibitorer | |
KR950703064A (ko) | 세포증식의 저해물질, 그의 제조방법 및 이용방법 | |
UA26853C2 (uk) | Спосіб одержаhhя стабільhого соматотропіhу, стабільhий соматотропіh і композиція стабільhого соматотропіhу | |
DE69214283T2 (de) | Verwendung von cellulase bei der zellstoffbehandlung | |
DE69531048D1 (de) | Verwendung von steroidsulphatase-hemmern | |
EP0599514A3 (en) | Pyranoquinoline derivatives as inhibitors of cell proliferation. | |
DK154492D0 (da) | Enzym | |
EE9900551A (et) | Tsüanoguanidiinid kui rakkude paljunemise inhibiitorid | |
KR900009566A (ko) | 말레이미드류의 제조법 | |
DK87592D0 (da) | Enzym | |
DK360189A (da) | S-adenosyl-methionin-decarboxylase-inhibitorer, deres fremstilling og anvendelse | |
NO943494D0 (no) | Eosinofil kjemotaksishemmer | |
FI961848A (fi) | Parannettu solunviljelymenetelmä ja -väliaine | |
IS4232A (is) | Súbstitúerað bensimidasól, aðferðir við framleiðslu þess og lyfjafræðileg notkun | |
DE69431454T2 (de) | Amylase Inhibitoren | |
IT1142141B (it) | Procedimento e substrato di fermentazione |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E601 | Decision to refuse application |